ENvue Medical, Inc. FEED
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -51.62% | -36.29% | -29.73% | 92.02% | -39.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -51.62% | -36.29% | -29.73% | 92.02% | -39.53% |
| Cost of Revenue | -4.54% | 7.93% | 323.60% | 119.34% | 35.99% |
| Gross Profit | -660.00% | -114.91% | -230.74% | 42.11% | -108.18% |
| SG&A Expenses | 60.62% | 88.53% | 149.88% | 159.37% | 219.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.81% | 51.69% | 118.96% | 120.58% | 199.80% |
| Operating Income | -37.68% | -100.38% | -167.15% | -131.65% | -489.91% |
| Income Before Tax | -25.38% | -104.04% | -830.65% | 154.77% | -471.49% |
| Income Tax Expenses | -103.23% | 120.00% | -8,480.00% | 1,066.67% | 1,450.00% |
| Earnings from Continuing Operations | -23.37% | -104.17% | -798.11% | 151.10% | -477.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.37% | -104.17% | -798.11% | 151.10% | -477.18% |
| EBIT | -37.68% | -100.38% | -167.15% | -131.65% | -489.91% |
| EBITDA | -45.49% | -90.51% | -148.32% | -105.15% | -436.30% |
| EPS Basic | -91.45% | -93.18% | -247.44% | 74.48% | -- |
| Normalized Basic EPS | 90.13% | -- | -- | 118.18% | -- |
| EPS Diluted | -91.45% | -93.18% | -247.44% | 74.48% | -- |
| Normalized Diluted EPS | 90.13% | -- | -- | 118.18% | -- |
| Average Basic Shares Outstanding | 1,170.05% | -- | -- | 205.56% | -- |
| Average Diluted Shares Outstanding | 1,170.05% | 1,071.37% | 292.31% | 205.56% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |